Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Direct detection of disease biomarkers in clinical specimens using cationic nanoparticle-based assays and versatile and green methods for synthesis of anisotropic silver nanostructures

Direct detection of disease biomarkers in clinical specimens using cationic nanoparticle-based assays and versatile and green methods for synthesis of anisotropic silver nanostructures

US Patent 10537106 · Granted Jan 21, 2020

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Ligands that target Plasmodium sporozoite binding sites on CD81 and therapeutic 2020
Chemosensors, compositions and uses thereof2019
Detection of nucleic acids using unmodified gold nanoparticles2018
Direct detection of unamplified hepatitis C virus RNA using unmodified gold nano2016